Cincinnati Cancer Advisors

Cincinnati Cancer Advisors CCA provides no-cost consultative oncology & genetic counseling services to Greater Cincinnati.

11/12/2025

Happy National Nurse Practitioner Week! 🩺

To celebrate, we're letting AI take our NP's to their most favorite places in the world. From beaches and mountains to rollercoasters and kitchens, they’ve certainly earned a little getaway.

We’re grateful for everything they do on the frontlines and behind the scenes. To all of the amazing NP's out there, thank you for being you. 💙

Your $100 donation supports no-cost second opinions for cancer patients AND enters you to win the Rivalry on the Rocks P...
11/09/2025

Your $100 donation supports no-cost second opinions for cancer patients AND enters you to win the Rivalry on the Rocks Package, including suite tickets to the Cincy vs. Cleveland football game, ultra rare bourbon, 2-night hotel stay at Lytle Park Hotel, $500 gift card and an on-air opportunity with iHeart radio. Only 1,500 chances available! Can we count you in?

No purchase necessary to enter. Click the link to learn more! https://secure.qgiv.com/for/egpzyp

ASCO Direct™ Best of Oncology Conference speaker spotlight: Dr. Arturo Loaiza-Bonilla, MD, MSEdLearn more and register f...
11/05/2025

ASCO Direct™ Best of Oncology Conference speaker spotlight: Dr. Arturo Loaiza-Bonilla, MD, MSEd

Learn more and register for our November 8th conference at the link in bio.

Bio: Dr. Arturo Loaiza-Bonilla, MD, MSEd, is the Systemwide Chief of Hematology and Oncology at St. Luke's University Health Network, leading a dynamic oncology team spanning 15 hospitals across 11 counties in Pennsylvania and New Jersey, all part of a nationally recognized healthcare system. He is also an ACS champion, media spokesperson, and the Co-Founder and Chief Medical Officer at Massive Bio, a global industry leader in connecting patients to clinical trials using artificial intelligence. An internationally renowned medical oncologist and researcher, Dr. Bonilla has a distinguished academic and clinical career in AI applications in healthcare, precision medicine oncology, immunotherapy, clinical trial design, digital health, entrepreneurship, and patient advocacy. Dr. Loaiza-Bonilla is board certified in both medical oncology and hematology and has extensive experience in the diagnosis and treatment of genomic biomarker-driven cancers.

Before joining St. Luke's, Dr. Loaiza-Bonilla was enterprise Chair of Research at Capital Health, and served as vice chairman of the Department of Medical Oncology at Cancer Treatment Centers of America / City of Hope in Philadelphia, Pennsylvania, as well as enterprise director of research, where he provided leadership and expertise to their oncology trial portfolio across 5 cancer centers and over 70 NCTN and industry-sponsored clinical trials. His research has been extensively published in the most prominent journals and meetings in oncology, and he has been recipient of NIH funding to advance digital health and artificial intelligence tools for cancer research. He was also Faculty at the University of Pennsylvania School of Medicine; Drexel University College of Medicine, and currently as Associate Professor at Lewis Katz School of Medicine at Temple University in Philadelphia.

Free expert second opinions? Sounds like a trick, right? 👻At Cincinnati Cancer Advisors, it’s all treats!Our expert team...
10/31/2025

Free expert second opinions? Sounds like a trick, right? đź‘»

At Cincinnati Cancer Advisors, it’s all treats!

Our expert team offers completely free second opinions and care consultations. No tricks, no hidden costs, just compassionate support when you need it most. When it comes to your health, you deserve the real treat: peace of mind. đź’ś

ASCO Direct™ Best of Oncology Conference speaker spotlight: Ishwaria Subbiah, MD, MS, FASCOLearn more and register for o...
10/30/2025

ASCO Direct™ Best of Oncology Conference speaker spotlight: Ishwaria Subbiah, MD, MS, FASCO

Learn more and register for our November 8th conference at the link in bio.

Bio: Ishwaria Subbiah, MD, MS, FASCO, is a palliative care & integrative medicine physician and medical oncologist based in Nashville, TN. With over 16 years of progressive responsibilities in care delivery and access optimization across academic centers, research institutes, and community practice networks, Dr. Subbiah hold an extensive expertise in navigating complex health systems to implement enterprise-level programs.

Dr. Subbiah completed clinical fellowships in early phase Drug Development, Medical Oncology, and Palliative Medicine at the University of Texas MD Anderson Cancer Center (Houston, TX), before joining the faculty and rising to Associate Professor. More recently, she has held leadership roles at MD Anderson and SCRI/US Oncology community practice network establishing enterprise-level programs in technology-enhanced supportive care, clinical trials access, and occupation wellbeing.

A 2024 National Academy of Medicine Change-Maker and ASCO Fellow, she serves as chair-elect for ASCO's Health Services Research Committee, JCO OP Associate Editor, and US President's Cancer Panel advisor. Her patient care, research, mentorship, and volunteerism all reflect her commitment to data-driven symptom management, clinical trials access, and workforce sustainability and wellbeing.

ASCO Direct™ Best of Oncology Conference speaker spotlight: Kerry S. Courneya, Ph.D.Learn more and register for our Nove...
10/28/2025

ASCO Direct™ Best of Oncology Conference speaker spotlight: Kerry S. Courneya, Ph.D.

Learn more and register for our November 8th conference at the link in bio.

Bio: Kerry S. Courneya, Ph.D., is a Professor in the Faculty of Kinesiology, Sport, and Recreation at the University of Alberta in Edmonton, Canada. His research program focuses on the role of exercise after a cancer diagnosis including how exercise might help cancer patients prepare for treatments, tolerate and respond to treatments, recover after treatments, and improve long-term outcomes. He has published over 600 peer reviewed scientific papers including many influential randomized controlled trials in colon, breast, prostate, lymphoma, and testicular cancer patients. He is study co-chair for the CHALLENGE trial which is the first phase 3 trial demonstrating a cancer-related survival benefit from a structured exercise program. In 2023, Prof. Courneya was appointed an Officer in the Order of Canada for his scientific contributions to the field of exercise oncology.

10/26/2025

Thank you for inviting us to be a part of Spooktacular Saturday! Don’t forget to support Element Eatery and CCA in October by “Sipping Pink” at the Garden Bar!

A cancer diagnosis can be scary, but getting a second opinion doesn’t have to be. Learn more about our expert, no-cost second opinions at CincinnatiCancerAdvisors.org.

ASCO Direct™ Best of Oncology Conference speaker spotlight: Mark Pegram, MDLearn more and register for our November 8th ...
10/22/2025

ASCO Direct™ Best of Oncology Conference speaker spotlight: Mark Pegram, MD

Learn more and register for our November 8th conference at the link in bio.

Bio: Mark Pegram, MD, is the Suzy Yuan-Huey Hung Endowed Professor of Medical Oncology at the Stanford University School of Medicine. He currently serves as the Associate Director of Clinical Research at the Stanford Comprehensive Cancer Institute (SCCI). He also serves as the Associate Dean for Clinical Research Quality at the Stanford University School of Medicine, and is the Medical Director of the Stanford Clinical Translational Research Unit – a unit specializing in first-in-human phase I clinical trials.

Dr Pegram received his medical degree from the University of North Carolina at Chapel Hill. He went on to complete an internship and residency at the University of Texas Southwestern Medical Center in Dallas. He concluded his training with a fellowship at the UCLA David Geffen School of Medicine in Los Angeles, CA.

Dr Pegram’s breast cancer research is focused on the study of the cancer-associated gene that encodes HER2 and on the development of novel agents in the treatment of patients with HER2-positive metastatic breast cancer. Dr Pegram has been educating other healthcare professionals about the future impact of biosimilars in oncology practice, especially in the breast cancer treatment landscape. He has authored more than 110 publications in medical oncology, hematology, and biosimilars across different cancer types.

ASCO Direct™ Best of Oncology Conference speaker spotlight: Alex Adjei MD, PhD, FACP, FASCOLearn more and register for o...
10/09/2025

ASCO Direct™ Best of Oncology Conference speaker spotlight: Alex Adjei MD, PhD, FACP, FASCO

Learn more and register for our November 8th conference here: https://ccabestofoncology.org/

Bio: Alex A. Adjei, MD, PhD, FACP, FASCO, is the Chief of the Cleveland Clinic Cancer Institute, overseeing cancer programs across Cleveland Clinic locations in Ohio, Florida, Abu Dhabi, and London. He is also the Director of the Taussig Cancer Center and holds a distinguished chair in Translational Cancer Research. Dr. Adjei has served on several US National Cancer Institute committees and is a member of the NCI Board of Scientific Counselors. He is editor-in-chief of the Journal of Thoracic Oncology and President-Elect of the International Association for the Study of Lung Cancer. His research focuses on experimental therapeutics and clinical drug development, with over 320 publications to his name.

This October, Element Eatery (EE) in Madison is turning pink! Throughout this   month, $1 of each drink sale from the Ga...
10/09/2025

This October, Element Eatery (EE) in Madison is turning pink!

Throughout this month, $1 of each drink sale from the Garden Bar’s featured drink menu will benefit the Cincinnati Cancer Foundation. EE’s Natalie Kaufman created the initiative in honor of her mother, Gwen, a former CCA patient, who passed away from breast cancer in August 2025.

Sip a cocktail or mocktail, raise a glass, and join us in supporting local cancer patients. Thank you, Element Eatery. Cheers!

ASCO Direct™ Best of Oncology Conference speaker spotlight: Bilal Siddiqui, MDLearn more and register for our November 8...
10/01/2025

ASCO Direct™ Best of Oncology Conference speaker spotlight: Bilal Siddiqui, MD

Learn more and register for our November 8th conference here: https://ccabestofoncology.org/

Bio: Dr. Siddiqui is an Assistant Professor in Genitourinary Medical Oncology at the University of Texas MD Anderson. He is a clinical and translational investigator with a focus on:1) biomarker-rich trials of novel immunotherapy strategies in prostate cancer, with a special emphasis on T cell engagers; and 2) improving outcomes in immune-mediated toxicities through identification of mechanistic biomarkers for early detection and rational intervention. He serves as a principal investigator on multiple clinical trials of T cell engagers in prostate cancer, including leading multicenter sponsored trials and investigator-initiated studies. He is a member of the MD Anderson IOTOX Leaders’ Group, meeting a critical need as immunotherapy combinations with higher rates of toxicities are growing rapidly. He has a special interest in immune-mediated myocarditis and myositis, which carry a high mortality rate. His recent work identified a novel population of IL-1-expressing macrophages in human heart tissue from patients with immune-mediated myocarditis that represents a potential therapeutic target for which a rational clinical trial is under development. The long-term goals of this work is to maximize efficacy and minimize toxicities of these immunotherapy strategies in patients.

While our team was having its weekly Best of Oncology conference planning meeting during lunch today, we received a surp...
09/29/2025

While our team was having its weekly Best of Oncology conference planning meeting during lunch today, we received a surprise visit from Dr. Leming's wife, Tracy, along with a massive bag of cheesecake from The Cheesecake Factory.

When asked what the surprise desserts were for, Tracy replied, "It's Philip Leming Day in Cincinnati!"

We then discovered a framed proclamation on Dr. Leming's office wall of many certificates, which the mayor declared September 29, 2022, was indeed "Philip D. Leming, M.D. Day." However, our team will continue celebrating our beloved Medical Director on this day every year.

"I want people to be able to feel that we listened, that we genuinely care, and that we will use all resources that exist on the planet Earth to improve their prognosis, their care, their life, or just give them hope that they are not without the potential of a better day tomorrow." - Dr. Philip Leming

Thank you for everything you do, Dr. Leming, and happy Philip D. Leming Day to all who celebrate 🎉

Address

4805 Montgomery Road, Suite 130
Cincinnati, OH
45212

Opening Hours

Monday 8:30am - 4:30pm
Tuesday 8:30am - 4:30pm
Wednesday 8:30am - 4:30pm
Thursday 8:30am - 4:30pm
Friday 8:30am - 4:30pm

Telephone

+15137312273

Alerts

Be the first to know and let us send you an email when Cincinnati Cancer Advisors posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Cincinnati Cancer Advisors:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram